BGT
BIOGENETEC FPO [BGT]
Healthcare · ASX Small Cap
$0.0170 +0.0%
Updated 23 Jul 2026 · Signals refresh every scan
Get alerts when BGT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Critical cash runway (1.7 quarters)
- Strong revenue growth (+208%)
- Near 52-week low (2% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- CANSLIM S: Tight float (44%)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +208% — the top line is moving in the right direction
- Altman Z-Score distress zone (0.74 < 1.81, low-confidence approx)
- Penny stock risk ($0.017)
- RBA hiking (-3pts)
- Calendar: Quarterly 4C in 8d (+5pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 44% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-3.16%/day)
Ask Scout AI about BGT
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Notice of Extraordinary General Meeting/Proxy Form
NONE Result of Security Purchase Plan
NONE Application for quotation of securities - BGT
Recent ASX Announcements
| 2026-07-06 | Notice of Extraordinary General Meeting/Proxy Form |
| 2026-06-23 | Result of Security Purchase Plan |
| 2026-06-23 | Application for quotation of securities - BGT |
| 2026-06-04 | Update - Proposed issue of securities - BGT |
| 2026-06-02 | Investor Update Webinar |
Key Metrics
$6.6M
Market Cap
607K
Avg Volume
0.3x
Vol Ratio
$0.02 — $0.06
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-202.2%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 44% |
| L | Leader vs Laggard | laggard | RS: -34 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
102 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track BGT and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required